Stocks and Investing
Stocks and Investing
Mon, January 30, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Luke Sergott Maintained (TWST) at Buy with Decreased Target to $37 on, Jan 30th, 2023
Luke Sergott of Barclays, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Decreased Target from $43 to $37 on, Jan 30th, 2023.
Luke has made no other calls on TWST in the last 4 months.
There are 4 other peers that have a rating on TWST. Out of the 4 peers that are also analyzing TWST, 1 agrees with Luke's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Puneet Souda of "SVB Leerink" Maintained at Hold with Decreased Target to $30 on, Monday, November 21st, 2022
These are the ratings of the 3 analyists that currently disagree with Luke
- Sung Ji Nam of "Scotiabank" Initiated at Buy and Held Target at $33 on, Thursday, January 5th, 2023
- Vijay Kumar of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $36 on, Tuesday, January 3rd, 2023
- Catherine Schulte of "Baird" Maintained at Buy with Decreased Target to $33 on, Monday, November 21st, 2022
Contributing Sources